Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

805 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories.
Bhavani SV, Spicer A, Sinha P, Malik A, Lopez-Espina C, Schmalz L, Watson GL, Bhargava A, Khan S, Urdiales D, Updike L, Dagan A, Davila H, Demarco C, Evans N, Gosai F, Iyer K, Kurtzman N, Palagiri AV, Sims M, Smith S, Syed A, Sarma D, Reddy B Jr, Verhoef PA, Churpek MM. Bhavani SV, et al. Among authors: sims m. Intensive Care Med. 2024 Dec;50(12):2094-2104. doi: 10.1007/s00134-024-07669-0. Epub 2024 Oct 9. Intensive Care Med. 2024. PMID: 39382693
The common, VTE-protective, G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.
Sims MC, Gierula M, Stephens JC, Tokolyi A, Stefanucci L, Persyn E, Sun L, Collins JH, Davenport E, Di Angelantonio E, Downes K, Inouye M, Paul DS, Thomas W, Tolios A, BioResource N, Ouwehand WH, Gleadall NS, Crawley JTB, Butterworth AS, Frontini M, Ahnstrom J. Sims MC, et al. Blood Adv. 2024 Oct 4:bloodadvances.2024014020. doi: 10.1182/bloodadvances.2024014020. Online ahead of print. Blood Adv. 2024. PMID: 39365993
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins.
Prokop JW, Alberta S, Witteveen-Lane M, Pell S, Farag HA, Bhargava D, Vaughan RM, Frisch A, Bauss J, Bhatti H, Arora S, Subrahmanya C, Pearson D, Goodyke A, Westgate M, Cook TW, Mitchell JT, Zieba J, Sims MD, Underwood A, Hassouna H, Rajasekaran S, Tamae Kakazu MA, Chesla D, Olivero R, Caulfield AJ. Prokop JW, et al. Among authors: sims md. Microorganisms. 2024 Sep 9;12(9):1863. doi: 10.3390/microorganisms12091863. Microorganisms. 2024. PMID: 39338537 Free PMC article.
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS; ECOSPOR III and ECOSPOR IV investigators. Kraft CS, et al. Among authors: sims m. Infect Dis Ther. 2024 Oct;13(10):2209-2210. doi: 10.1007/s40121-024-01036-8. Infect Dis Ther. 2024. PMID: 39212853 Free PMC article. No abstract available.
805 results